Shanghai Sunway Biotech
China - ShanghaiBiotechnology
Focus: Shanghai Sunway Biotech is a China-based biotechnology company focused on biologics development, currently advancing fixed-dose combination HIV antiretroviral therapies. The company operates as a mid-cap biotech with a narrow therapeutic focus on infectious diseases.
Profile data last refreshed 4h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Shanghai Sunway Biotech
AI assessmentNot HiringNo open roles listed right now. Follow Shanghai Sunway Biotech to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Shanghai Sunway Biotech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Pre-Launch
Fixed-dose combination of three antiretroviral agents currently pending regulatory approval; represents the company's sole disclosed product candidate.
Help build intelligence for Shanghai Sunway Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.